Did You Lose Money in Semler Scientific, Inc.? If You Suffered Significant Financial Loss in SMLR Contact Robbins LLP for Information About Leading the SMLR Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for failing to disclose a material investigation by the U.S. Department of Justice regarding potential violations of the False Claims Act [2][3]. Group 1: Allegations and Investigations - The lawsuit alleges that Semler Scientific did not disclose an investigation by the DOJ into possible violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [2]. - On February 28, 2025, Semler Scientific revealed it had received an initial civil investigative demand from the DOJ in July 2017, concerning the marketing of tests using photoplethysmography technology as reimbursable by Medicare [3]. - Following unsuccessful settlement discussions with the DOJ on February 11, 2025, there was a risk of a civil lawsuit being filed, which led to a stock price drop of $4.03, or 9.38%, closing at $38.89 on March 3, 2025 [3]. Group 2: Settlement and Financial Impact - On April 15, 2025, Semler Scientific reported to the SEC that it had reached a settlement agreement with the DOJ for $29.75 million, excluding attorney fees, but noted that further payments might be necessary and the risk of a DOJ lawsuit still exists [4]. - Following the announcement of the settlement, Semler Scientific's stock fell by $3.40 per share, or 9.88%, closing at $31.00 on April 16, 2025 [4]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their paperwork by October 28, 2025, to serve as lead plaintiff, representing other class members [5]. - Shareholders do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [5].